Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.

about

The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.

P2860

Q33599835-39295E43-B1EF-4591-ACBF-C7FB58679D2A

P2860

Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.

Item

http://www.wikidata.org/entity/Q39236752

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Palosuran treatment effective ...... lmonary arterial hypertension.

@en

Palosuran treatment effective ...... lmonary arterial hypertension.

@nl

type

Item

label

Palosuran treatment effective ...... lmonary arterial hypertension.

@en

Palosuran treatment effective ...... lmonary arterial hypertension.

@nl

prefLabel

Palosuran treatment effective ...... lmonary arterial hypertension.

@en

Palosuran treatment effective ...... lmonary arterial hypertension.

@nl

P1476

Palosuran treatment effective ...... ulmonary arterial hypertension

@en

P2093

Ahmet Mesut Onat

http://www.w3.org/2001/XMLSchema#string

Ali Osman Ceribasi

http://www.w3.org/2001/XMLSchema#string

Bunyamin Kisacik

http://www.w3.org/2001/XMLSchema#string

Davut Sinan Kaplan

http://www.w3.org/2001/XMLSchema#string

Ediz Tutar

http://www.w3.org/2001/XMLSchema#string

Ibrahim Halil Turkbeyler

http://www.w3.org/2001/XMLSchema#string

Ibrahim Koc

http://www.w3.org/2001/XMLSchema#string

Mustafa Orkmez

http://www.w3.org/2001/XMLSchema#string

Seyithan Taysi

http://www.w3.org/2001/XMLSchema#string

Tuncer Demir

http://www.w3.org/2001/XMLSchema#string

P2860

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

Is urotensin-II the new endothelin?

Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1

Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System

Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

Urotensin II in the cardiovascular system.

Urotensin-II and cardiovascular remodeling.

Urotensin-II receptor modulators as potential drugs.

Novel approaches to treat experimental pulmonary arterial hypertension: a review.

P2888

s10753-014-9855-8

P304

1280-1288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10753-014-9855-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Recep Dokuyucu

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260611601

http://www.w3.org/2001/XMLSchema#string

P698

24604341

http://www.w3.org/2001/XMLSchema#string

Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.

about

P2860

P2860

Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698